Patient Recruitment into a Multicenter Randomized Clinical Trial for Kidney Disease: Report of the Focal Segmental Glomerulosclerosis Clinical Trial (FSGS CT)

Maria Ferris, Victoria Norwood, Milena Radeva, Jennifer J. Gassman, Amira Al-Uzri, David Askenazi, Tej Matoo, Maury Pinsk, Amita Sharma, William Smoyer, Jenna Stults, Shefali Vyas, Robert Weiss, Debbie Gipson, Frederick Kaskel, Aaron Friedman, Marva Moxey-Mims, Howard Trachtman

Research output: Contribution to journalArticle

10 Scopus citations

Abstract

We describe the experience of the focal segmental glomerulosclerosis clinical trial (FSGS CT) in the identification and recruitment of participants into the study. This National Institutes of Health funded study, a multicenter, open-label, randomized comparison of cyclosporine versus oral dexamethasone pulses plus mycophenolate mofetil, experienced difficulty and delays meeting enrollment goals. These problems occurred despite the support of patient advocacy groups and aggressive recruitment strategies. Multiple barriers were identified including: (1) inaccurate estimates of the number of potential incident FSGS patients at participating centers; (2) delays in securing one of the test agents; (3) prolonged time between IRB approval and execution of a subcontract (mean 7.5 ± 0.8 months); (4) prolonged time between IRB approval and enrollment of the first patient at participating sites (mean 19.6 ± 1.4 months); and (5) reorganization of clinical coordinating core infrastructure to align resources with enrollment. A Web-based anonymous survey of site investigators revealed site-related barriers to patient recruitment. The value of a variety of recruitment tools was of marginal utility in facilitating patient enrollment. We conclude that improvements in the logistics of study approval and regulatory start-up and testing of promising novel agents are important factors in promoting enrollment into randomized clinical trials in nephrology.

Original languageEnglish (US)
Pages (from-to)13-20
Number of pages8
JournalClinical and translational science
Volume6
Issue number1
DOIs
StatePublished - Feb 2013

Keywords

  • Clinical trials
  • Kidney
  • Nephrology
  • Pediatrics

Fingerprint Dive into the research topics of 'Patient Recruitment into a Multicenter Randomized Clinical Trial for Kidney Disease: Report of the Focal Segmental Glomerulosclerosis Clinical Trial (FSGS CT)'. Together they form a unique fingerprint.

  • Cite this

    Ferris, M., Norwood, V., Radeva, M., Gassman, J. J., Al-Uzri, A., Askenazi, D., Matoo, T., Pinsk, M., Sharma, A., Smoyer, W., Stults, J., Vyas, S., Weiss, R., Gipson, D., Kaskel, F., Friedman, A., Moxey-Mims, M., & Trachtman, H. (2013). Patient Recruitment into a Multicenter Randomized Clinical Trial for Kidney Disease: Report of the Focal Segmental Glomerulosclerosis Clinical Trial (FSGS CT). Clinical and translational science, 6(1), 13-20. https://doi.org/10.1111/cts.12003